BioCentury
ARTICLE | Clinical News

PEG-hemoglobin: Will start clinical trials in normal volunteers for safety and dose-ranging

January 30, 1995 8:00 AM UTC

Enzon Inc. (ENZN), Piscataway, N.J. Product: PEG-hemoglobin, bovine hemoglobin attached to polyethylene glycol to disguise it from the immune system Indication: Improve effectiveness of radiation ther...